Eocene Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company was founded by Allen Baharaff and Tuvia Gilat in 2000 and is headquartered in Tel Aviv, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
6
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Eocene Ltd. market cap is $1.85M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Eocene Ltd. 52 week high is $10.08 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Eocene Ltd. 52 week low is $1.75 as of November 22, 2026.
Eocene Ltd. stock price today is $1.78.
Eocene Ltd. stock price yesterday was $1.75.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Eocene Ltd.'s P/E ratio is -0.13.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Eocene Ltd. P/B ratio is 0.1399.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Eocene Ltd. 50-day moving average is $3.08.